BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 32394720)

  • 1. Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes.
    Wang X; Luke AA; Vader JM; Maddox TM; Joynt Maddox KE
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006284. PubMed ID: 32394720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Sex Inequities in the Use of and Outcomes After Left Ventricular Assist Device Implantation Among Medicare Beneficiaries.
    Cascino TM; Somanchi S; Colvin M; Chung GS; Brescia AA; Pienta M; Thompson MP; Stewart JW; Sukul D; Watkins DC; Pagani FD; Likosky DS; Aaronson KD; McCullough JS
    JAMA Netw Open; 2022 Jul; 5(7):e2223080. PubMed ID: 35895063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the Affordable Care Act Medicaid Expansion Linked to Change in Rate of Ventricular Assist Device Implantation for Blacks and Whites?
    Breathett KK; Knapp SM; Wightman P; Desai A; Mazimba S; Calhoun E; Sweitzer NK
    Circ Heart Fail; 2020 Apr; 13(4):e006544. PubMed ID: 32233662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices.
    Kilic A; Seese L; Pagani F; Kormos R
    J Am Heart Assoc; 2020 Apr; 9(8):e015449. PubMed ID: 32285751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular complications associated with percutaneous left ventricular assist device placement: A 10-year US perspective.
    Patel N; Sharma A; Dalia T; Rali A; Earnest M; Tadros P; Wiley M; Hockstad E; Mehta A; Thors A; Hance K; Gupta K
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):309-316. PubMed ID: 31638737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of insurance type on eligibility for advanced heart failure therapies and survival.
    Hutcheson SS; Phillips V; Patzer R; Smith A; Vega JD; Morris AA
    Clin Transplant; 2018 Aug; 32(8):e13328. PubMed ID: 29905971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of Left Ventricular Assist Devices in Vulnerable Adults Across Medicaid Expansion.
    Ehsan A; Zeymo A; McDermott J; Shara NM; Sellke FW; Yousefzai R; Al-Refaie WB
    J Surg Res; 2019 Nov; 243():503-508. PubMed ID: 31377490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septuagenarian population has similar survival and outcomes to younger patients after left ventricular assist device implantation.
    Galand V; Flécher E; Chabanne C; Lelong B; Goéminne C; Vincentelli A; Delmas C; Dambrin C; Nubret K; Pernot M; Kindo M; Hoang Minh T; Gaudard P; Frapier JM; Michel M; Sénage T; Boignard A; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Litlzer PY; Anselme F; Babatasi G; Plane AF; Garnier F; Bielefeld M; Hamon D; Radu C; Bourguignon T; Genet T; Eschalier R; D'Ostrevy N; Bories MC; Marijon E; Vanhuyse F; Blangy H; Leclercq C; Martins RP
    Arch Cardiovasc Dis; 2020 Nov; 113(11):701-709. PubMed ID: 32952086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sociodemographic differences in utilization and outcomes for temporary cardiovascular mechanical support in the setting of cardiogenic shock.
    Thangam M; Luke AA; Johnson DY; Amin AP; Lasala J; Huang K; Joynt Maddox KE
    Am Heart J; 2021 Jun; 236():87-96. PubMed ID: 33359779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in access to left ventricular assist device therapy.
    Joyce DL; Conte JV; Russell SD; Joyce LD; Chang DC
    J Surg Res; 2009 Mar; 152(1):111-7. PubMed ID: 18466923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Joint Association of Septicemia and Cerebrovascular Diseases with In-Hospital MortalityAmong Patients with Left Ventricular Assist Device in the United States.
    Lovelace J; Shabaneh O; De La Cruz N; Owoade DR; Nwabuo CC; Nair N; Appiah D
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105610. PubMed ID: 33482570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, Predictors, and Prognostic Value of Residual Tricuspid Regurgitation in Patients With Left Ventricular Assist Device.
    Nakanishi K; Homma S; Han J; Takayama H; Colombo PC; Yuzefpolskaya M; Garan AR; Farr MA; Kurlansky P; Di Tullio MR; Naka Y; Takeda K
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29937432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary Experience of Extracorporeal Cytokine Hemoadsorption during Left Ventricular Assist Device Implantation in Cardiogenic Shock Patients.
    Pausch J; Mersmann J; Bhadra OD; Barten MJ; Alassar YA; Schulte-Uentrop L; Reichenspurner H; Bernhardt AM
    Thorac Cardiovasc Surg; 2024 Jun; 72(4):266-272. PubMed ID: 36216331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-Based Differences in Left Ventricular Assist Device Utilization: Insights From the Nationwide Inpatient Sample 2004 to 2016.
    Joshi AA; Lerman JB; Sajja AP; Dahiya G; Gokhale AV; Dey AK; Kyvernitakis A; Halbreiner MS; Bailey S; Alpert CM; Poornima IG; Murali S; Benza RL; Kanwar M; Raina A
    Circ Heart Fail; 2019 Sep; 12(9):e006082. PubMed ID: 31514517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Heart Failure Medication Use and Adherence Following Left Ventricular Assist Device Implantation in Privately Insured Patients.
    Tan NY; Sangaralingham LR; Schilz SR; Dunlay SM
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of acute kidney injury after left ventricular assist device implantation: Evaluation of clinical risk scores.
    Pilarczyk K; Carstens H; Papathanasiou M; Luedike P; Koch A; Jakob H; Kamler M; Pizanis N
    Artif Organs; 2020 Feb; 44(2):162-173. PubMed ID: 31361341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival.
    Brewer RJ; Cabrera R; El-Atrache M; Zafar A; Hrobowski TN; Nemeh HM; Selektor Y; Paone G; Williams CT; Velez M; Tita C; Morgan JA; Lanfear DE
    Int J Artif Organs; 2014 Nov; 37(11):834-8. PubMed ID: 25450319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.